Tokyo-based genome data analysis firm Euglena found that those with rs671 genotypes of ALDH2 are more predisposed to liking coffee and more prevalent in people from the Kansai area than other parts of Japan.
Euglena tested 20,000 people from all over Japan and discovered which prefectures have the most and least number of genetically predisposed coffee lovers.
There is a considerably stronger concentration of coffee lovers in the Kansai region, composed of prefectures such as Osaka and Kyoto.
There were of the six main Kansai prefectures appear in the top ten genetically coffee-loving prefectures.
The ALDH2, which controls the enzymes used in alcohol metabolism, is the same gene that results in the facial redness of many East Asians who partake of alcohol.
Conversely, those from the geographic extremities of Japan seem to be less susceptible to the aroma of freshly brewed coffee. The southern islands of Okinawa came in dead last among prefectures and northernmost Hokkaido ranked 41st out of 47.
Interestingly, the same prefectures that tested high for genetic predilection for liking coffee also have the most coffee shops per capita.
The science behind it is could eventually identify potential lifestyle illnesses based on genetics.


NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 



